FMR CORP 13D/13G Filings for Ambrx Biopharma Inc. (AMAM)

FMR CORP 13D and 13G filings for Ambrx Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
08:23 am
Sale		 2023-02-09 13G Ambrx Biopharma Inc.
AMAM		 FMR CORP 18,872,448
6.981%		 -7,936,866decrease
(-29.60%)		 Filing
2022-03-10
09:48 am
Sale		 2022-03-09 13G Ambrx Biopharma Inc.
AMAM		 FMR CORP 26,809,314
10.683%		 -175,861decrease
(-0.65%)		 Filing
2022-02-09
09:09 am
Purchase		 2022-02-08 13G Ambrx Biopharma Inc.
AMAM		 FMR CORP 26,985,175
9.996%		 26,985,175increase
(New Position)		 Filing